Abstract: Scrub typhus is an acute febrile illness in the "tsutsugamushi triangle", transmitted by chiggers that can be treated effectively if detected early. Laboratory testing, including molecular and serological assays, is needed for confirming the diagnosis, especially in the absence of the pathognomonic eschar. In this review, factors that play a role in disease occurrence and clinical clues for diagnosis, in addition to risk factors contributing to disease severity, including mortality, are discussed in detail. Moreover, issues related to diagnostic assays, treatment, and mixed infections are also enumerated and described.
Introduction

Risk factors for acquiring scrub typhus
The abundance of the chigger of the trombiculid mite, which is the vector for scrub typhus, determines the chance of acquiring scrub typhus, which in turn determines the prevalence of scrub typhus in a given region. 4 There is always a spurt of cases during certain seasons in the endemic areas described, and this varies from country to country and is dependent on the climate 1 and environment. Additionally, within a country, certain regions show increased prevalence.
Chiggers are abundant in locales with high relative humidity (60%-85%), low temperature (20°C-30°C), low incidence of sunlight, and a dense substrate-vegetative canopy. 2, 30, 31 As such, they are found in great numbers in forest clearings, riverbanks, and grassy regions. Humans acquire scrub typhus on exposure to infected larvae (chiggers) of trombiculid mites. The density of chiggers of Leptotrombidium pallidum and L. scutellare is very high from September to November in South Korea, with a consequent rise in scrub typhus in humans. This provides evidence that an increase in chigger density of the vector species is responsible for the high seasonal prevalence in endemic areas. 17 This variation in chigger activity gives rise to the seasonality of scrub typhus.
Peak prevalence in South Korea occurs in autumn ( September-November), in Japan increased cases are observed in autumn and winter, in north China (Shandong) in September-November, and in south China in June-September. In south India, scrub-typhus cases occur mostly in the cooler months (August-January), while in Southeast Asia scrub-typhus cases are highest in July-November. 32 Incidence of scrub typhus can vary from country to country and also region in large countries like India and China. It has been reported that each 1°C and 1% change in temperature can cause an increase in incidence, 16 as evidenced by a 15% rise in scrub-typhus cases in Guangzhou, China. 8 In addition to temperature, secondary vegetation and rainfall also increase the incidence of scrub typhus. 33 Occupational risk is higher in farmers (aged 50-69 years), females, 6 and those working in vegetable fields, harvesting in autumn, 34 and rural highlands. 35 In a study by Kweon et al, outdoor activities like resting on a grass field without a mat, working in short sleeves and bare hands, and defecating and/or urinating outdoors while squatting increased risk for scrub typhus. 12 In a case-control study from South Korea, individuals engaged in fruit farming, gathering chestnuts, and taking breaks in areas adjacent to agricultural operations had an increased risk of contracting scrub typhus compared to controls. The authors opined that providing a health-education program would lower the risk in these individuals and similar groups. 36 Land use is another determinant, as scrub-typhus incidence increases when forest lands are converted to fields, palm oil, and rubber plantations, 2 and also when urbanization occurs.
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Clinical clues favoring a diagnosis of scrub typhus Presence of eschars
The presence of eschars is considered pathognomonic. It has been reported that eschar incidence varies from 7% to 97% in endemic areas 5 and is painless. 37 Eschars are often found in covered areas of the body, such as the groin, axilla, chest, and lower back, including the buttocks. 9, 10, [38] [39] [40] Recently, there have been reports of multiple eschars 41, 42 and atypical eschars, 43 which were punched-out ulcers with slough. This could also be due to the original eschar scab being removed by scratching 44 or falling away, especially during bathing. This seems plausible, because the eschar appears at the chigger-bite site a few days before the onset of symptoms. 37 Therefore, a thorough examination becomes necessary and improves eschar detection, leading in turn to improvement in the diagnosis of scrub typhus in a clinical setting. This has been observed at our center: eschar incidence improved from 45 to 55% in 2013. 46 Eschars of scrub typhus appear a few days after at chigger-bite sites, before the disease manifests. The eschar is painless and consists of a black scab, with an erythematous halo and minimal edema. 44, 47 Detection of eschars is dependent not only on the clinical experience of the examining physician but is also influenced by skin color (eschars are more easily seen on the fair-skinned than the dark-complexioned) and also on the thoroughness of the physical examination. 48 The differentials for a scrub-typhus eschar include insect bites (including spider bites) and posttraumatic scabs, 49 which can all be ruled out with a little patience and perseverance. The eschar of anthrax, though painless, is surrounded by extensive or marked edema that is gelatinous and stretches the skin, and is often preceded by a pruritic papule. 50, 51 
Use of clinical prediction rules
As given in Table 1 , a few clinical clues other than eschars are available for suspecting or diagnosing scrub typhus in the clinic or at the bedside. It is to be noted that even at a referral hospital in endemic countries, the diagnosis of scrub typhus is usually based on the clinical findings. 54 As definitive diagnosis requires laboratory testing, clinical prediction rules have been tried. Chen et al observed a 100% negative predictive value for clinical criteria combining the presence of eschars, atypical lymphocytes in peripheral blood smear, and contact history. 59 A clinical rule formulated for scrub typhus by Jung et al uses five predictors with a maximum score of 8 points. The scoring criteria include age ≥65 years (2 points), recent history of fieldwork/outdoor activities (1 point), onset of illness during an outbreak period of scrub typhus (2 points), myalgia (1 point), and eschars (2 points). A score below 3 rules out scrub typhus, while 100% sensitivity was observed for a score ≥3. the authors felt that this could be used for selecting patients for empirical therapy in resource-poor situations or for performing specific laboratory tests. 23 Similarly, Siriwongpan et al devised and validated a clinical risk scoring system using a set of 526 patients with scrub typhus based on the World Health Organization (WHO) case definition. [60] [61] [62] Risk factors determining severity and outcome in scrub typhus Severity of disease based on genotype
The severity of scrub typhus varies considerably, which might correlate with the virulence of the particular O. tsutsugamushi strain responsible for the infection. There is evidence that frequency of eschars and rash in scrub typhus is dependent on the infecting genotype. South Korean individuals with the Boryong genotype have significantly higher incidence (97%) of eschars and skin rash compared to 74% with the Karp genotype. 63 Karp genotypes (summer scrub typhus, isolated in Guangdong, Fujian, Hainan provinces in southern China) were found to be more virulent and caused more severe disease than Kawasaki genotypes (autumn-winter scrub typhus) isolated in Shandong and northern Jiangsu provinces in northern China. 48 Eschar presence was not significant in severe and nonsevere scrub typhus. 64 
Clinical and laboratory parameters predicting severity in scrub typhus
Patients with possible scrub typhus with low body temperature, rapid pulse rate, presence of crepitation, low percentage of lymphocytes, low serum albumin, elevated aspartate aminotransferase, elevated serum creatinine, and positive urine albumin should be monitored closely for severity progression. 60 Tables 2 and 3 provide a summary of the significant features predicting severity and outcome of scrub typhus. Parameters that show very significant P-values (0.01) by multivariate logistic regression analysis have been included in the tables. In a meta-analysis of 89 studies (19,644 patients with scrub typhus), fatal outcome was reported in 2,488 patients, with an overall mortality of 12.7%. Though increasing age 
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Prakash was associated with fatality, presence or absence of eschars did not affect the outcome. 65 
Laboratory diagnosis of scrub typhus
Scrub typhus can mimic other acute febrile illnesses common in the tropics, especially when pathognomonic eschars are absent. 10 Therefore, laboratory tests become mandatory for confirmation of the diagnosis. 38, 75, 76 Methods available include direct methods like isolation of the pathogen in cell cultures (HeLa, L929, Vero, and BHK21) and detection of scrub typhus-specific DNA like 56 kDa, 47 kDa, 16S ribosomal RNA, and GroEL gene targets by polymerase chain reaction (PCR). Indirect methods include detection of antibodies to O. tsutsugamushi by immunofluorescence assay (IFA), enzyme-linked immunosorbent assay (ELISA), 77 and rapid diagnostic assays. 78, 79 Tables 4 and 5 give performance characteristics of the available assays for laboratory confirmation of scrub typhus.
Real-time PCR assays like the 47 kDa, 56 kDa, and GroEL are increasingly used, and these detect 10-50 copies/ μL of O. tsutsugamushi. Real-time PCR specificity is higher if type-specific genes are used (eg, 56 kDa and 47 kDa genes for O. tsutsugamushi) than if genus-specific genes are used (17 kDa genes for Rickettsia spp.), which again are stronger than nonspecific conserved "housekeeping" genes like HSPD1 (GroEL) and 16S ribosomal RNA. 27 The drawback 
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Scrub typhus overview of molecular assays is that the best yield is seen with eschar biopsy, followed by buffy coat, whole blood, and blood clots. 29, 38, [80] [81] [82] As obtaining eschar biopsies is challenging, eschar-swab specimens have been used and found to be adequate for detection of scrub typhus-specific DNA. 29, 82 In contrast to eschar PCR, buffy-coat positivity by PCR (scrub typhus) falls to 10%, 4 days after treatment. 83 Sometimes, typical eschars are not observed, and in such situations PCR or immunohistochemical staining methods using eschar-like crust lesions will be useful. 80, 84 Though determination of scrub-typhus antibodies is the mainstay of scrub-typhus diagnosis, 85 definitive evidence of causation by serology is provided only when paired sera demonstrate a fourfold rise in titer or seroconversion. 86 As paired sera are seldom available, a single cutoff titer for IFA, ELISA, and rapid diagnostic tests can be used for diagnosis, provided the background noise in the population has been determined. 76, 87, 88 Serology can determine past and recent exposure to O. tsutsugamushi, and thus is useful for disease surveillance. 82 Though considered the gold standard, IFA is now under threat as the reference test for scrub-typhus diagnosis. 5, 7, 29, 49, 82, 88, 89 The IFA (which uses cell culture-grown O. tsutsugamushi as antigens) can be used to differentiate IgM and IgG classes of antibodies. It is semiquantitative, as antibody concentration is reported as a titer (inverse of the highest dilution giving a positive reaction). Moreover, it requires fluorescence microscopy, is very labor-intensive, and despite adequate training of personnel is reported to have a high incidence of interassay and intra-assay variability. 5, 38, 88 ELISA, on the other hand, can be automated and thus used to screen large numbers of sera, is objective (optical density value), economical, technically simpler, and able to detect antibody levels also. 82 Due to strain variation, 56 kDa antigen cocktails are being used for detection of scrub-typhus antibodies. 90 As there is evidence that ELISA is more accurate than IFA, 48 it is being recommended as an alternative to the IFA. 88, 89, 91 Rapid diagnostic tests are becoming important, as a rapid diagnosis can be made with a certain degree of certainty, especially in endemic areas. 79 The Weil-Felix agglutination test is definitely a cheap option for diagnosis of rickettsial infections, including scrub typhus, in resource-poor settings. 76 Though it has poor sensitivity, it can have good specificity 85, 92 and is a good test in resource-poor situations for demonstrating the presence of scrub typhus or rickettsioses, though most workers feel it has poor specificity. 76, 82 Bayesian latent-class modeling has been used to determine diagnostic test performance, as it does not consider any test as perfect. 49 In addition, composite criteria involving culture, PCR, and serological positivity like scrub typhusinfection criteria have been used. 81 Moreover, a WHO case definition for scrub typhus also is available, 93 as is an expert-derived Indian Council of Medical Research case definition. 94 Lim et al concluded that combinations of IgM ICT and presence of eschars have good specificity and can be 
100
Note: *An evaluation done using 24 eschar samples from scrub typhus-confirmed cases showed sensitivity and specificity of 83.3% and 100%, respectively (Prakash, unpublished data, 2012 
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Prakash used in resource-poor situations as point-of-care diagnostic tests, whereas performance of a PCR would be very useful in centers with facilities for same.
49
Coinfections and scrub typhus
In endemic areas, coinfections have been described, and these include infections with other pathogens causing similar illness. Table 6 enumerates the grading of coinfections according to Phommasone et al, 27 and Tables 7 and 8 describe  such infections. A few scenarios are described for our understanding. The first is by Sonthayanon et al, who found that among the 82 serological coinfections observed, molecular assays were positive for leptospirosis in 43 (52%), scrub typhus in nine (11%), and both in five (6%), whereas 25 (30%) were negative for both leptospirosis and scrub typhus. Possible explanations for the difference observed between serologic and molecular results include low sensitivity of the molecular assay, failure to test a sample obtained during the window of bacteremia in leptospirosis, serologic cross-reactivity, and acute infection caused by one pathogen in the background of a recent but inactive infection caused by the second pathogen. 128 Second, in the presence of eschars, testing for Leptospira serology is unwarranted, according to Lee and Liu, as four of the seven cases who were Leptospira serology-positive had eschars. 26 As treatment with doxycycline or azithromycin is very effective against Leptospira and Orientia, serological cross-reaction or coinfection does not matter, as treatment with either will be beneficial to the patient with an acute febrile illness when both serologies are positive. 129 Third, dual and triple infections occur, as reported by Ahmad et al, who described malaria, dengue, and scrub typhus in five cases, 21 were dengue cross-reactive, malaria smears were positive in 14, and nine individuals had IgM antibodies to scrub typhus and dengue. Further clarification regarding which was a cross-reaction could have been determined if information regarding presence or absence of 53 
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Culture and/or PCR Leptospira (MAT) 139 
1
IFA Leptospira (MAT) 140 1 IFA Severe fever with thrombocytopenia syndrome (PCR) 141 
3
IFA Grade III Leptospira (MAT) 142 9 Dot-blot assay Dengue (NS1 antigen) 131 
6
IgM ELISA Leptospira (IgM ELISA) 143 
8
IgM ELISA Dengue (IgM ELISA) 130 Malaria (smear) 130 
14
IgM ELISA Spotted fever, group rickettsia (IFA) 
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Scrub typhus overview eschars was available 130 or determination of NS1-antigen positivity, as was done by Basheer et al. 131 
Management challenges
Atypical clinical features and absence of eschars may result in delayed diagnosis, complications, or death. 76 Scrub typhus responds promptly to effective treatment, with patients becoming afebrile within 24-48 hours, 41, 94 so much so that when enteric fever, septicemia, and malaria are ruled out, empirical treatment with doxycycline (even when given late in the disease) is clinically useful. 146 Therefore, empirical therapy with doxycycline is to be encouraged in regions or locales where scrub typhus is endemic or reemerging. This will lead to a reduction in complications, with a corresponding decrease in morbidity and mortality. 146 Treatment for scrub typhus has been reviewed extensively by Peter et al 86 and Rajapakse et al. 147 Doxycycline is useful as an empirical treatment, because of its high cost-effectiveness and wide spectrum of activity, and is considered safe in children <8 years of age. 44 There is grade B evidence for lack of dental staining in children given short-course doxycycline, as may be given in scrub typhus. [148] [149] [150] [151] Moreover, doxycycline reaches good concentrations in cerebrospinal fluid, as does minocycline, though use of the latter is limited by dose-related vestibular side effects. 151 Fluoroquinolones are not good drugs for treatment, 150, 152 nor are penicillins, clarithromycin, and cephalosporins. 153 O. tsutsugamushi with reduced susceptibility has been observed for doxycycline and chloramphenicol in Chiang Rai, northern Thailand. [154] [155] [156] This may not have been true resistance, but due to delayed treatment or tolerance.
Data on scrub typhus in pregnancy are scanty. Among the 82 cases reviewed from the literature till 2014 by McGready et al, 2.5% were associated with maternal mortality. Miscarriage occurred in 17%, and poor neonatal outcomes (stillbirth, preterm labor, and low birth weight) were documented in 42%. Macrolide antibiotics, such as azithromycin, are safe in pregnancy, but doxycycline, which is cheaper, can also be used if the former is not available. 157 The aim of therapy is to save both mother and child, 158 and the benefits of therapy with doxycycline outweigh the risks. [148] [149] [150] [151] Cross et al opined that doxycycline treatment should be used in children and pregnant women for treating scrub typhus, as the infectionassociated risks are too large and thus overwhelmingly against avoiding therapy with this agent. 151 Recently, Jang et al reported that intravenous azithromycin was efficacious in the treatment of severe scrub typhus. 159 The major concern is that misdiagnosis occurs when the characteristic eschars are absent. 153 This is of importance, as treatment with an appropriate antibiotic (doxycycline, tetracycline, or chloramphenicol) renders patients afebrile within 48 hours, such that pyrexia persisting beyond 72 hours rules out scrub typhus. Such patients have jaundice (icteric sclera and/or total bilirubin >1.5 mg/dL), no headache, and relative bradycardia (<110/min).
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Conclusion
Scrub typhus is an important cause of febrile illness in the Asia-Pacific region. The main management challenge is institution of specific therapy in a timely and an effective manner, as stated elsewhere in this review. For this, rapid and accurate diagnosis becomes necessary, especially in the absence of eschars. In resource-poor endemic settings, clinical prediction rules have been defined and found useful. In addition, a battery of tests is needed for increasing diagnostic yield and sorting out the issue of coinfections. Finally, appropriate treatment should be initiated, keeping in mind the risk and benefits afforded by such treatment.
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